Core Viewpoint - The stock of TEBIO has experienced a decline of 8.58% since the beginning of the year, with significant trading activity noted on January 15, 2025, where the stock price reached 76.50 CNY per share, reflecting a market capitalization of 31.23 billion CNY [1] Group 1: Stock Performance - On January 15, 2025, TEBIO's stock rose by 2.08%, with a trading volume of 1.11 billion CNY and a turnover rate of 0.36% [1] - The stock has seen a decline of 6.79% over the last five trading days, 8.16% over the last twenty days, and 2.61% over the last sixty days [1] Group 2: Financial Performance - For the period from January to September 2025, TEBIO reported a revenue of 2.48 billion CNY, representing a year-on-year growth of 26.85%, and a net profit attributable to shareholders of 666 million CNY, which is a 20.21% increase year-on-year [2] - Since its A-share listing, TEBIO has distributed a total of 577 million CNY in dividends, with 506 million CNY distributed over the past three years [2] Group 3: Shareholder Information - As of September 30, 2025, TEBIO had 8,608 shareholders, an increase of 2.00% from the previous period, with an average of 47,258 circulating shares per shareholder, a decrease of 1.96% [2] - The top ten circulating shareholders include notable ETFs, with E Fund's SSE STAR 50 ETF holding 5.88 million shares, down by 856,700 shares from the previous period, and Huaxia's SSE STAR 50 Component ETF holding 5.73 million shares, down by 3.22 million shares [2]
特宝生物涨2.08%,成交额1.11亿元,主力资金净流入1272.30万元